ACC 2011 Schedule: Difference between revisions
No edit summary |
|||
(53 intermediate revisions by 4 users not shown) | |||
Line 20: | Line 20: | ||
[[{{PAGENAME}}#Tuesday April 5, 2011|Tuesday April 5, 2011]] | [[{{PAGENAME}}#Tuesday April 5, 2011|Tuesday April 5, 2011]] | ||
---- | ---- | ||
==Friday April 1, 2011== | ==Friday April 1, 2011== | ||
=== | ===1:30 PM=== | ||
OPEN TIME SLOT | OPEN TIME SLOT | ||
''[[ACC 2011 Schedule#Click on Date for Detailed Schedule|Return to top]]'' | ''[[ACC 2011 Schedule#Click on Date for Detailed Schedule|Return to top]]'' | ||
==Saturday April 2, 2011== | ==Saturday April 2, 2011== | ||
===5:00 PM=== | ===5:00 PM=== | ||
Line 75: | Line 39: | ||
==Sunday April 3, 2011== | ==Sunday April 3, 2011== | ||
===9:00 AM=== | ===<font color=red>9:00 AM</font>=== | ||
''9:00 AM - 9:30 AM'' | |||
*'''Interviewee:''' Dr. Yukihiro Koretsune | |||
*'''Trial:''' RE-LY Japanese data | |||
*'''Embargo lift:''' | |||
===9:30 AM=== | ===9:30 AM=== | ||
OPEN TIME SLOT | OPEN TIME SLOT | ||
===10:00 AM=== | ===10:00 AM=== | ||
Line 87: | Line 54: | ||
OPEN TIME SLOT | OPEN TIME SLOT | ||
===11:00 AM=== | ===<font color=red>11:00 AM</font>=== | ||
''11:00 AM - 11:30 AM'' | |||
*'''Interviewee:''' Dr. Martin Leon | |||
*'''Trial:''' One Year Clinical Outcomes from the Pivotal Multicenter RESOLUTE US Study | |||
*'''Embargo lift:''' Monday April 4th, 12:15pm | |||
===1:00 PM=== | ===1:00 PM=== | ||
OPEN TIME SLOT | OPEN TIME SLOT | ||
===1:30 PM=== | ===<font color=red>1:30 PM</font>=== | ||
''1:30 PM - 2:00 PM'' | |||
*'''Interviewee:''' Dr. John Bisognano | |||
*'''Trial:''' Baroreflex Activation Therapy Sustainably Lowers Blood Pressure in Patients with Resistant Hypertension: Results from the Rheos Pivotal Trial | |||
*'''Embargo lift:''' Tuesday April 5th, 12:15pm | |||
===2:00 PM=== | ===<font color=red>2:00 PM</font>=== | ||
''2:00 PM - 2:30 PM'' | |||
*'''Interviewee:''' Dr. Carlo Briguori | |||
*'''Trial:''' Renal Insufficiency Following Contrast Media Administration Trial Ii (REMEDIAL II): Renalguard System In High-risk Patients For Contrast-induced Acute Kidney Injury | |||
*'''Embargo lift:''' Monday April 4th, 12:15pm | |||
===2:30 PM=== | ===2:30 PM=== | ||
OPEN TIME SLOT | OPEN TIME SLOT | ||
===<font color=red>3:00 PM</font>=== | |||
===<font color=red> | |||
''3:00 PM - 3:30 PM'' | ''3:00 PM - 3:30 PM'' | ||
*'''Interviewee:''' Dr. Julinda Mehilli | *'''Interviewee:''' Dr. Julinda Mehilli | ||
Line 112: | Line 84: | ||
*'''Embargo lift:''' Monday April 4th, 12:15pm | *'''Embargo lift:''' Monday April 4th, 12:15pm | ||
===<font color=red>3:30 PM</font>=== | |||
''3:30 PM - 4:00 PM'' | |||
*'''Interviewee:''' Dr. Stephen E. Fremes | |||
*'''Trial:''' Radial Artery and Saphenous Vein Patency More than Five Years Following Coronary Artery Bypass Surgery: Results from the Randomized Multicentre Radial Artery Patency Study (RAPS) | |||
*'''Embargo lift:''' Monday April 4th, 9:30am | |||
=== | ===<font color=red>4:00 PM</font>=== | ||
''4:00 PM - 4:30 PM'' | |||
*'''Interviewee:''' Dr. Morten Schou | |||
*'''Trial:''' Nt-probnp Stratified Long-term Follow-up in Outpatient Heart Failure Clinics: A Prospective Randomized Multicenter Trial in Danish Heart Failure Clinics Network | |||
*'''Embargo lift:''' Tuesday April 5th, 12:15pm | |||
===4: | ===<font color=red>4:30 PM</font>=== | ||
''4:30 PM - 5:00 PM'' | |||
*'''Interviewee:''' Dr. Goto | |||
*'''Trial:''' RE-LY Japanese data | |||
*'''Embargo lift:''' | |||
=== | ===<font color=red>5:00 PM</font>=== | ||
''5:00 PM - 5:30 PM'' | |||
*'''Interviewee:''' Dr. Sunil Rao | |||
*'''Topic:''' LBCT's in the Radial World | |||
''[[ACC 2011 Schedule#Click on Date for Detailed Schedule|Return to top]]'' | ''[[ACC 2011 Schedule#Click on Date for Detailed Schedule|Return to top]]'' | ||
Line 129: | Line 111: | ||
==Monday April 4, 2011== | ==Monday April 4, 2011== | ||
===9:00 AM=== | ===<font color=red>9:00 AM</font>=== | ||
''9:00 AM - 9:30 AM'' | |||
*'''Interviewee:''' Dr. Sanjit Jolly | |||
*'''Trial:''' Rival Trial: A Randomized Comparison of Radial versus Femoral Access for Coronary Angiography or Intervention in Patients with Acute Coronary Syndromes | |||
*'''Embargo lift:''' Monday April 4th, 12:15pm | |||
===9:30 AM=== | ===<font color=red>9:30 AM</font>=== | ||
''9:30 AM - 10:00 AM'' | |||
*'''Interviewee:''' Dr. Gilles Montalescot | |||
*'''Topic:''' French ACC Wrap-up | |||
===10:00 AM=== | ===<font color=red>10:00 AM</font>=== | ||
''10:00 AM - 10:30 AM'' | |||
*'''Interviewee:''' Dr. John D. Puskas | |||
*'''Trial:''' Reduced Anticoagulation for a Mechanical Heart Valve | |||
*'''Embargo lift:''' Tuesday April 5th, 12:15pm | |||
===10:30 AM=== | ===10:30 AM=== | ||
Line 144: | Line 134: | ||
OPEN TIME SLOT | OPEN TIME SLOT | ||
=== | ===<font color=red>2:30 PM</font>=== | ||
''2:30 PM - 3:00 PM'' | |||
*'''Interviewee:''' Dr. Basil Lewis | |||
*'''Topic:''' Israeli ACC Wrap-up | |||
* Interviewee: Dr. | |||
* | |||
===<font color=red>3:00 PM</font>=== | |||
''3:00 PM - 3:30 PM'' | |||
*'''Interviewee:''' Dr. Robert Bonow | |||
*'''Trial:''' Influence of Myocardial Viability on Outcome of Patients with Coronary Artery Disease and Left Ventricular Function Undergoing Medical Therapy with and without Surgical Revascularization: Results of the Surgical Treatment for Ischemic Heart Failure Trial | |||
*'''Embargo lift:''' Monday April 4th, 9:30am | |||
===<font color=red> | ===<font color=red>3:30 PM</font>=== | ||
'' | ''3:30 PM - 4:00 PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Gregg Stone | ||
*'''Trial:''' | *'''Trial:''' A Prospective, Randomized, Investigation of a Novel Platinum Chromium Everolimus-Eluting Coronary Stent: The PLATINUM Trial | ||
*'''Embargo lift:''' | *'''Embargo lift:''' Monday April 4th, 12:15pm | ||
=== | ===<font color=red>4:00 PM</font>=== | ||
''4:00 PM - 4:30 PM'' | |||
*'''Interviewee:''' Dr. Freek.W.A. Verheugt | |||
*'''Topic:''' Dutch ACC Wrap-up | |||
=== | ===<font color=red>4:30 PM</font>=== | ||
''4:30 PM - 5:00 PM'' | |||
*'''Interviewee:''' Dr. Craig Smith | |||
*'''Trial:''' Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement in "High Risk" Patients with Aortic Stenosis: The Randomized PARTNER Trial | |||
*'''Embargo lift:''' Sunday April 3rd, 10:00am | |||
=== | ===<font color=red>5:00 PM</font>=== | ||
''5:00 PM - 5:30 PM'' | |||
*'''Interviewee:''' Dr. Eric Velazquez | |||
*'''Trial:''' Medical Therapy with or without Coronary Artery Bypass Graft Surgery in Patients with Ischemic Cardiomyopathy: Results of the Surgical Treatment of Ischemic Heart Failure Trial | |||
*'''Embargo lift:''' Monday April 4th, 9:30 am | |||
=== | ===<font color=red>5:30 PM</font>=== | ||
''5:30 PM - 6:00 PM'' | |||
*'''Interviewee:''' Dr. A. Michael Lincoff | |||
*'''Trial:''' Selective Inhibition of Delta Protein Kinase C to Reduce Infarct Size after Primary Percutaneous Intervention for Acute Myocardial Infarction: The PROTECTION-AMI Phase IIb Clinical Trial | |||
*'''Embargo lift:''' Tuesday April 5, 9:30am | |||
''[[ACC 2011 Schedule#Click on Date for Detailed Schedule|Return to top]]'' | ''[[ACC 2011 Schedule#Click on Date for Detailed Schedule|Return to top]]'' | ||
Line 185: | Line 178: | ||
==Tuesday April 5, 2011== | ==Tuesday April 5, 2011== | ||
=== | ===<font color=red>8:00 AM</font>=== | ||
''8:00 AM - 8:30 AM'' | |||
*'''Interviewee:''' Dr. Paul Armstrong | |||
*'''Topic:''' Canadian ACC Wrap-up | |||
===9: | ===<font color=red>9:00 AM</font>=== | ||
''9:00 AM - 9:30 AM'' | |||
*'''Interviewee:''' Dr. Renato Lopes | |||
*'''Topic:''' ACC Wrap-up in Portuguese | |||
=== | ===<font color=red>9:30 AM</font>=== | ||
''9:30 AM - 10:00 AM'' | |||
*'''Interviewee:''' Dr. Lars Wallentin | |||
*'''Topic:''' ACC Wrap-up: Scandinavia | |||
===10: | ===<font color=red>10:00 AM</font>=== | ||
''10:00 AM - 10:30 AM'' | |||
*'''Interviewee:''' Dr. Sergio Leonardi and Dr. Giuseppe Patti | |||
*'''Topic:''' ACC Wrap-up in Italian | |||
===<font color=red> | ===<font color=red>10:150 AM</font>=== | ||
'' | ''10:15 AM - 10:30 AM'' | ||
*'''Interviewee:''' | *'''Interviewee:''' Gibson and Harrington Wrap-Up | ||
*''' | *'''Topic:''' ACC Wrap-up | ||
*''' | ===<font color=red>10:30 AM</font>=== | ||
''10:30 AM - 11:00 AM'' | |||
*'''Interviewee:''' Dr. Harvey White | |||
*'''Topic:''' ACC Wrap-up: Pacific Rim | |||
===11: | ===<font color=red>11:00 AM</font>=== | ||
''11:00 AM - 11:30 AM'' | |||
*'''Interviewee:''' Dr. Hisao Ogawa | |||
*'''Trial:''' The Comparison of High-Dose Angiotensin II Receptor Blocker (ARB) Monotherapy versus Combination Therapy of ARB with Calcium Channel Blocker on Cardiovascular Events in Japanese Elderly High-Risk Hypertensive Patients: Olmesartan and Calcium Antagonists Randomized (OSCAR) Study | |||
*'''Embargo lift:''' Tuesday April 5th, 9:30am | |||
===<font color=red>11:30 AM</font>=== | |||
''11:30 AM - 12:00 PM'' | |||
*'''Interviewee:''' Dr. Hisao Ogawa | |||
*'''Topic:''' ACC Wrap-up in Japanese on RE-LY subanalysis | |||
===<font color=red>1:00 PM</font>=== | ===<font color=red>1:00 PM</font>=== | ||
Line 219: | Line 228: | ||
OPEN TIME SLOT | OPEN TIME SLOT | ||
===2:00 PM=== | ===<font color=red>2:00 PM</font>=== | ||
''2:00 PM - 2:30 PM'' | |||
*'''Interviewee:''' Dr. Toyoaki Murohara | |||
*'''Trial:''' Comparison between Valsartan and Amlodipine Regarding Cardiovascular Morbidity and Mortality in Hypertensive Patients with Glucose Intolerance (NAGOYA HEART Study) | |||
*'''Embargo lift:''' Tuesday April 5th, 9:30am | |||
===2:30 PM=== | ===2:30 PM=== | ||
OPEN TIME SLOT | OPEN TIME SLOT | ||
''[[ACC 2011 Schedule#Click on Date for Detailed Schedule|Return to top]]'' | ''[[ACC 2011 Schedule#Click on Date for Detailed Schedule|Return to top]]'' |
Latest revision as of 18:25, 30 March 2011
Here is the page we will use to coordinate interviews at ACC 2011
Filming location:
Filming will occur from Saturday to Tuesday (April 2nd-April 5th). Dr. Gibson is available to interview during all times listed in black. For all times listed in red, Dr. Gibson is unavailable to conduct the interview. As a presenter, you should go ahead and speak about your topic/present your slides.
Click on Date for Detailed Schedule
Friday April 1, 2011
1:30 PM
OPEN TIME SLOT
Saturday April 2, 2011
5:00 PM
OPEN TIME SLOT
Sunday April 3, 2011
9:00 AM
9:00 AM - 9:30 AM
- Interviewee: Dr. Yukihiro Koretsune
- Trial: RE-LY Japanese data
- Embargo lift:
9:30 AM
OPEN TIME SLOT
10:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
11:00 AM - 11:30 AM
- Interviewee: Dr. Martin Leon
- Trial: One Year Clinical Outcomes from the Pivotal Multicenter RESOLUTE US Study
- Embargo lift: Monday April 4th, 12:15pm
1:00 PM
OPEN TIME SLOT
1:30 PM
1:30 PM - 2:00 PM
- Interviewee: Dr. John Bisognano
- Trial: Baroreflex Activation Therapy Sustainably Lowers Blood Pressure in Patients with Resistant Hypertension: Results from the Rheos Pivotal Trial
- Embargo lift: Tuesday April 5th, 12:15pm
2:00 PM
2:00 PM - 2:30 PM
- Interviewee: Dr. Carlo Briguori
- Trial: Renal Insufficiency Following Contrast Media Administration Trial Ii (REMEDIAL II): Renalguard System In High-risk Patients For Contrast-induced Acute Kidney Injury
- Embargo lift: Monday April 4th, 12:15pm
2:30 PM
OPEN TIME SLOT
3:00 PM
3:00 PM - 3:30 PM
- Interviewee: Dr. Julinda Mehilli
- Trial: Long-Term Outcomes after Use of Drug-Eluting Stents and Bare Metal Stents for the Treatment of Saphenous Vein Graft Lesions: Results of the Randomized ISAR-CABG Trial
- Embargo lift: Monday April 4th, 12:15pm
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Dr. Stephen E. Fremes
- Trial: Radial Artery and Saphenous Vein Patency More than Five Years Following Coronary Artery Bypass Surgery: Results from the Randomized Multicentre Radial Artery Patency Study (RAPS)
- Embargo lift: Monday April 4th, 9:30am
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Dr. Morten Schou
- Trial: Nt-probnp Stratified Long-term Follow-up in Outpatient Heart Failure Clinics: A Prospective Randomized Multicenter Trial in Danish Heart Failure Clinics Network
- Embargo lift: Tuesday April 5th, 12:15pm
4:30 PM
4:30 PM - 5:00 PM
- Interviewee: Dr. Goto
- Trial: RE-LY Japanese data
- Embargo lift:
5:00 PM
5:00 PM - 5:30 PM
- Interviewee: Dr. Sunil Rao
- Topic: LBCT's in the Radial World
Monday April 4, 2011
9:00 AM
9:00 AM - 9:30 AM
- Interviewee: Dr. Sanjit Jolly
- Trial: Rival Trial: A Randomized Comparison of Radial versus Femoral Access for Coronary Angiography or Intervention in Patients with Acute Coronary Syndromes
- Embargo lift: Monday April 4th, 12:15pm
9:30 AM
9:30 AM - 10:00 AM
- Interviewee: Dr. Gilles Montalescot
- Topic: French ACC Wrap-up
10:00 AM
10:00 AM - 10:30 AM
- Interviewee: Dr. John D. Puskas
- Trial: Reduced Anticoagulation for a Mechanical Heart Valve
- Embargo lift: Tuesday April 5th, 12:15pm
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Dr. Basil Lewis
- Topic: Israeli ACC Wrap-up
3:00 PM
3:00 PM - 3:30 PM
- Interviewee: Dr. Robert Bonow
- Trial: Influence of Myocardial Viability on Outcome of Patients with Coronary Artery Disease and Left Ventricular Function Undergoing Medical Therapy with and without Surgical Revascularization: Results of the Surgical Treatment for Ischemic Heart Failure Trial
- Embargo lift: Monday April 4th, 9:30am
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Dr. Gregg Stone
- Trial: A Prospective, Randomized, Investigation of a Novel Platinum Chromium Everolimus-Eluting Coronary Stent: The PLATINUM Trial
- Embargo lift: Monday April 4th, 12:15pm
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Dr. Freek.W.A. Verheugt
- Topic: Dutch ACC Wrap-up
4:30 PM
4:30 PM - 5:00 PM
- Interviewee: Dr. Craig Smith
- Trial: Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement in "High Risk" Patients with Aortic Stenosis: The Randomized PARTNER Trial
- Embargo lift: Sunday April 3rd, 10:00am
5:00 PM
5:00 PM - 5:30 PM
- Interviewee: Dr. Eric Velazquez
- Trial: Medical Therapy with or without Coronary Artery Bypass Graft Surgery in Patients with Ischemic Cardiomyopathy: Results of the Surgical Treatment of Ischemic Heart Failure Trial
- Embargo lift: Monday April 4th, 9:30 am
5:30 PM
5:30 PM - 6:00 PM
- Interviewee: Dr. A. Michael Lincoff
- Trial: Selective Inhibition of Delta Protein Kinase C to Reduce Infarct Size after Primary Percutaneous Intervention for Acute Myocardial Infarction: The PROTECTION-AMI Phase IIb Clinical Trial
- Embargo lift: Tuesday April 5, 9:30am
Tuesday April 5, 2011
8:00 AM
8:00 AM - 8:30 AM
- Interviewee: Dr. Paul Armstrong
- Topic: Canadian ACC Wrap-up
9:00 AM
9:00 AM - 9:30 AM
- Interviewee: Dr. Renato Lopes
- Topic: ACC Wrap-up in Portuguese
9:30 AM
9:30 AM - 10:00 AM
- Interviewee: Dr. Lars Wallentin
- Topic: ACC Wrap-up: Scandinavia
10:00 AM
10:00 AM - 10:30 AM
- Interviewee: Dr. Sergio Leonardi and Dr. Giuseppe Patti
- Topic: ACC Wrap-up in Italian
10:150 AM
10:15 AM - 10:30 AM
- Interviewee: Gibson and Harrington Wrap-Up
- Topic: ACC Wrap-up
10:30 AM
10:30 AM - 11:00 AM
- Interviewee: Dr. Harvey White
- Topic: ACC Wrap-up: Pacific Rim
11:00 AM
11:00 AM - 11:30 AM
- Interviewee: Dr. Hisao Ogawa
- Trial: The Comparison of High-Dose Angiotensin II Receptor Blocker (ARB) Monotherapy versus Combination Therapy of ARB with Calcium Channel Blocker on Cardiovascular Events in Japanese Elderly High-Risk Hypertensive Patients: Olmesartan and Calcium Antagonists Randomized (OSCAR) Study
- Embargo lift: Tuesday April 5th, 9:30am
11:30 AM
11:30 AM - 12:00 PM
- Interviewee: Dr. Hisao Ogawa
- Topic: ACC Wrap-up in Japanese on RE-LY subanalysis
1:00 PM
1:00 PM - 1:30 PM
- Interviewee: Dr. Ted Feldman
- Trial: EVEREST II Randomized Clinical Trial: Two Year Outcomes
- Embargo lift: Monday April 4th, 9:30am
1:30 PM
OPEN TIME SLOT
2:00 PM
2:00 PM - 2:30 PM
- Interviewee: Dr. Toyoaki Murohara
- Trial: Comparison between Valsartan and Amlodipine Regarding Cardiovascular Morbidity and Mortality in Hypertensive Patients with Glucose Intolerance (NAGOYA HEART Study)
- Embargo lift: Tuesday April 5th, 9:30am
2:30 PM
OPEN TIME SLOT